Knowledge Distillery

Filter the news according their assigned tags.
| Interventional study with open label/non-randomised methodology  

The authors investigated the safety, vaccine efficacy, and immunogenicity of two doses of AZD1222 as compared with placebo in preventing the onset of…

more...
| Interventional study with open label/non-randomised methodology  

Evaluation of the effects of therapeutic-dose low-molecular-weight heparin vs institutional standard prophylactic or intermediate-dose heparins for…

more...
| Interventional study with open label/non-randomised methodology  

The objective of this study was to determine whether convalescent plasma would improve outcomes for critically ill adults with COVID-19.

more...
| Interventional study with open label/non-randomised methodology  

In this randomised, controlled, open-label, platform trial, several possible treatments were compared with usual care in patients hospitalised with…

more...
| Interventional study with open label/non-randomised methodology  

In this article the authors aimed to report the results of a substudy within a phase 3 UK trial, by evaluating the safety, immunogenicity, and…

more...
| Interventional study with open label/non-randomised methodology  

In this study the authors did a multicentric, open-label, Bayesian randomised, adaptive, phase 2/3 clinical trial, nested within the CORIMUNO-19…

more...
| Interventional study with open label/non-randomised methodology  

Our highlighted selection of Covid-related interventional studies with open label or non-randomised methodology from the scientific press for January…

more...
| Interventional study with open label/non-randomised methodology  

Our highlighted selection of Covid-related interventional studies with open label or non-randomised methodology from the scientific press for February…

more...
| Interventional study with open label/non-randomised methodology  

Multiple early reports of patients admitted to hospital with COVID-19 showed that patients with chronic respiratory disease were significantly…

more...
| Interventional study with open label/non-randomised methodology  

Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies

more...
| Interventional study with open label/non-randomised methodology  

BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine encoding a prefusion-stabilized, membrane-anchored severe acute…

more...
| Interventional study with open label/non-randomised methodology  

SARS-CoV-2 entry in human cells depends on angiotensin-converting enzyme 2, which can be upregulated by inhibitors of the renin–angiotensin system…

more...